|
| As a woman, a health professional, a patient and consumer of bioidentical hormones, I urge that you not entertain the suggestion to limit their availability. There is a valuable place for them in our clinical armamentarium and suitable safeguards (prescription by physician, compounding by licensed physicians) in place and sufficient evidence of their safety and efficacy. Current law and policy is adequate and changes not needed...should an individual pharmacy be in flagrant violation of the law its activity should be curtailed using existing standards and mechanisms for enforcement. This effort by a major pharmaceutical company to restrict the choices available for patients and their physicians looks suspiciously like restraint of trade. Please do not erase the progress that has been made during the previous decades in our attention to the unique health care concerns of women.
|
|